Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2-/<i>ERBB2</i>-Altered Advanced Biliary Tract Cancers.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39102636.
- Also identified by DOI 10.1200/JCO.24.00868.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<i>The Oncology Grand Rounds series is designed to place original reports published in the</i> Journal <i>into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in</i> Journal of Clinical Oncology<i>, to patients seen in their own clinical practice.</i>
Medical subject headings
- Biliary Tract Neoplasms
- Erb-b2 Receptor Tyrosine Kinases